Portland, OR, United States of America

David Ngene

This inventor holds 18 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Nike, Inc., Pacmodo Inc.. Active years: 2017-2026.

USPTO Granted Patents = 18 

% Patents Active = 94.4

 

Average Co-Inventor Count = 1.2

ph-index = 9

Forward Citations = 374(Granted Patents)


Location History:

  • Beaverton, OR (US) (2017 - 2019)
  • Portland, OR (US) (2017 - 2021)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Journey of David Ngene

Introduction

David Ngene is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of footwear design, particularly through his work at Nike, Inc. With a total of 18 patents to his name, Ngene has established himself as a key player in the industry.

Latest Patents

Among his latest innovations is a groundbreaking shoe design that showcases his commitment to enhancing athletic performance and comfort. This patent reflects his ability to blend functionality with style, making a lasting impact on the market.

Career Highlights

Ngene's career at Nike, Inc. has been marked by his dedication to innovation and excellence. His work has not only contributed to the company's success but has also set new standards in the footwear industry. His inventive spirit continues to inspire those around him.

Collaborations

Throughout his career, Ngene has collaborated with talented individuals such as Andrew Zubko and Sh Park. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge products.

Conclusion

David Ngene's journey as an inventor exemplifies the power of innovation in the footwear industry. His contributions and collaborations have left a significant mark, and his future endeavors are eagerly anticipated.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…